Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in

NCT06099366 is registered in ClinicalTrials.gov with Hee Young Ju as lead sponsor.

NCT NCT06099366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06099366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in
Lead sponsor
Hee Young Ju
Phase
Phase 2
Overall status
Recruiting
Start date
March 5, 2024
Completion date
December 31, 2033
Enrollment
116 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic leukemia in children